Sébastien P. Tabruyn

3.1k citations

36 papers · 2.4k indexed · 1 hit paper · h-index 26

Molecular Biology top 5%
Cancer Research top 2%
Oncology top 5%
Cardiology and Cardiovascular Medicine top 5%
Surgery top 10%

Co-authors: Arjan W. Griffioen Ingrid Struman Joseph Martial Donald M. McDonald Ngoc-Quynh-Nhu Nguyen Karolien Castermans Agnès Noël Vincent Bours
Topics: Angiogenesis and VEGF in Cancer (11 papers)Cancer, Hypoxia, and Metabolism (5 papers)NF-κB Signaling Pathways (5 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: Belgium United States Netherlands

In The Last Decade

Sébastien P. Tabruyn

35 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

2013 380 citations Julie Halkein, Sébastien P. Tabruyn et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Sébastien P. Tabruyn

Since Specialization

Citations

This map shows the geographic impact of Sébastien P. Tabruyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien P. Tabruyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien P. Tabruyn more than expected).

Fields of papers citing papers by Sébastien P. Tabruyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien P. Tabruyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien P. Tabruyn. The network helps show where Sébastien P. Tabruyn may publish in the future.

Co-authorship network of co-authors of Sébastien P. Tabruyn

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien P. Tabruyn. A scholar is included among the top collaborators of Sébastien P. Tabruyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien P. Tabruyn. Sébastien P. Tabruyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The assembly of cancer-specific ribosomes by the lncRNA LISRR suppresses melanoma anti-tumor immunity 2025 ·The Journal of Experimental Medicine ·(unknown),(unknown),(unknown),(unknown),(unknown),Roberto Vendramin,Alessandro Cuomo,Joanna Poźniak,(unknown),Marcella Baldewijns,Sébastien P. Tabruyn,Oliver Bechter,Maria Francesca Baietti,Elisabetta Groaz,Tiziana Bonaldi,Eleonora Leucci	0
2	Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System 2023 ·International Journal of Molecular Sciences ·(unknown),Marja Talikka,Alain Sewer,Nicolas Sierro,(unknown),(unknown),(unknown),Rémi Dulize,Emmanuel Guedj,Patrick Nef,Sébastien P. Tabruyn,Julia Hoeng,Manuel C. Peitsch,Giuseppe Lo Sasso	4
3	CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells 2018 ·Cancer Research ·Walid Warda,Fabrice Larosa,(unknown),(unknown),Éric Deconinck,Ziad Fajloun,Cyril Faure,Denis Caillot,(unknown),Séverine Valmary‐Degano,Sabeha Biichlé,Étienne Daguindau,Francine Garnache‐Ottou,Sébastien P. Tabruyn,Olivier Adotévi,Marina Deschamps,Christophe Ferrand	68
4	CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL 2016 ·Cancer Research ·Benoît Manfroi,Thomas McKee,(unknown),Sébastien P. Tabruyn,Sébastien Moret,Christian Villiers,Christian Righini,Martin J.S. Dyer,Mary Callanan,Pascal Schneider,Alexandar Tzankov,Thomas Matthes,Nathalie Stürm,Bertrand Huard	55
5	Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity 2016 ·Proceedings of the National Academy of Sciences ·(unknown),Tilman M. Hackeng,Sébastien P. Tabruyn,Wouter C. Puijk,Klaus Schwamborn,Danièle Altschuh,Rob H. Meloen,T. Schuurman,Arjan W. Griffioen,Peter Timmerman	28
6	GATA2 is required for lymphatic vessel valve development and maintenance 2015 ·Journal of Clinical Investigation ·Jan Kazenwadel,Kelly L. Betterman,Chan‐Eng Chong,Philippa H. Stokes,Young Kyung Lee,Genevieve A. Secker,(unknown),Cansaran Saygili Demir,David Lawrence,(unknown),Sébastien P. Tabruyn,Naoyuki Miura,Marjo Salminen,Tatiana V. Petrova,Jacqueline M. Matthews,Christopher N Hahn,Hamish S. Scott,Natasha L. Harvey	159
7	miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization 2014 ·Molecular Oncology ·Karmele Valencia,Diego Luis-Ravelo,Nicolas Bovy,Iker Antón,Susana Martínez-Canarias,Carolina Zandueta,C. Ormazábal,Ingrid Struman,Sébastien P. Tabruyn,Vera Rebmann,Javier De Las Rivas,Elizabeth Guruceaga,Eva Bandrés,Fernando Lecanda	143
8	MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathybreakdown → 2013 ·Journal of Clinical Investigation ·Julie Halkein,Sébastien P. Tabruyn,Melanie Ricke‐Hoch,Aiden Haghikia,Ngoc-Quynh-Nhu Nguyen,Michaela Scherr,Karolien Castermans,Ludovic Malvaux,Vincent Lambert,Marc Thiry,Karen Sliwa,Agnès Noël,Joseph Martial,Denise Hilfiker‐Kleiner,Ingrid Struman	380
9	Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors 2012 ·Cancer Discovery ·Barbara Sennino,Toshina Ishiguro‐Oonuma,Ying Wei,Ryan M. Naylor,Casey W. Williamson,Vikash Bhagwandin,Sébastien P. Tabruyn,Weon‐Kyoo You,Harold A. Chapman,James G. Christensen,Dana T. Aftab,Donald M. McDonald	325
10	Pericyte Requirement for Anti-Leak Action of Angiopoietin-1 and Vascular Remodeling in Sustained Inflammation 2011 ·American Journal Of Pathology ·Jonas Fuxe,Sébastien P. Tabruyn,Katharine Colton,Harras B. Zaid,(unknown),Peter Bałuk,Erin Lashnits,Tohru Morisada,Tom Le,Shaun O’Brien,David Epstein,Gou Young Koh,Donald M. McDonald	72
11	Angiopoietin/Tie2 Signaling Transforms Capillaries into Venules Primed for Leukocyte Trafficking in Airway Inflammation 2010 ·American Journal Of Pathology ·Jonas Fuxe,Erin Lashnits,Shaun O’Brien,Peter Bałuk,Sébastien P. Tabruyn,Frank Kuhnert,Calvin J. Kuo,Gavin Thurston,Donald M. McDonald	29
12	Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis 2010 ·Molecular Cancer ·Céline Sabatel,Anne Cornet,Sébastien P. Tabruyn,Ludovic Malvaux,Karolien Castermans,Joseph Martial,Ingrid Struman	22
13	Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation 2010 ·American Journal Of Pathology ·Sébastien P. Tabruyn,Katharine Colton,Tohru Morisada,Jonas Fuxe,Stanley J. Wiegand,Gavin Thurston,Anthony J. Coyle,Jane R. Connor,Donald M. McDonald	51
14	Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors 2009 ·Cancer Research ·Barbara Sennino,Frank Kuhnert,Sébastien P. Tabruyn,Michael R. Mancuso,Dana D. Hu‐Lowe,Calvin J. Kuo,Donald M. McDonald	43
15	NF-κB: a new player in angiostatic therapy 2008 ·Angiogenesis ·Sébastien P. Tabruyn,Arjan W. Griffioen	100
16	Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways 2007 ·Biochemical Pharmacology ·Catherine Verhaeghe,Caroline Remouchamps,Benoît Hennuy,Alain Vanderplasschen,Alain Chariot,Sébastien P. Tabruyn,Cécile Oury,Vincent Bours	83
17	Inhibition of Tumor Growth and Metastasis Establishment by Adenovirus-mediated Gene Transfer Delivery of the Antiangiogenic Factor 16K hPRL 2007 ·Molecular Therapy ·Ngoc-Quynh-Nhu Nguyen,Anne Cornet,Silvia Blacher,Sébastien P. Tabruyn,Jean‐Michel Foidart,Agnès Noël,Joseph Martial,Ingrid Struman	29
18	A new role for NF-κB in angiogenesis inhibition 2007 ·Cell Death and Differentiation ·Sébastien P. Tabruyn,Arjan W. Griffioen	46
19	Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature 2006 ·Molecular Pharmacology ·Sabine Olivier,Pierre Close,Emilie Castermans,Laurence de Leval,Sébastien P. Tabruyn,Alain Chariot,Michel Malaise,Marie‐Paule Merville,Vincent Bours,Nathalie Franchimont	41
20	The Antiangiogenic Factor 16K Human Prolactin Induces Caspase-Dependent Apoptosis by a Mechanism that Requires Activation of Nuclear Factor-κB 2003 ·Molecular Endocrinology ·Sébastien P. Tabruyn,(unknown),Françoise Rentier‐Delrue,Vincent Bours,Richard I. Weiner,Joseph Martial,Ingrid Struman	73

About Sébastien P. Tabruyn

Sébastien P. Tabruyn is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 36 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Cancer, Hypoxia, and Metabolism (5 papers) and NF-κB Signaling Pathways (5 papers). The work is most often cited by research in Cancer Research (767 citations), Oncology (587 citations) and Molecular Biology (1.3k citations). Sébastien P. Tabruyn has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Arjan W. Griffioen, Ingrid Struman, Joseph Martial, Donald M. McDonald, Ngoc-Quynh-Nhu Nguyen, Karolien Castermans, Agnès Noël, Vincent Bours, Barbara Sennino and Marc Thiry. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact